The global microbiology testing market size was exhibited at USD 5.33 billion in 2023 and is projected to attain around USD 11.76 billion by 2032, growing at a CAGR of 9.2% during the forecast period 2023 to 2032.
Microbiology testing plays a crucial role in public health, scientific research, and clinical diagnostics. This field highly focuses on the study of microorganisms such as viruses, algae, fungi, bacteria, and parasites, as well as their impact on the environment and human health. Microorganisms are ubiquitous in the environment, and they are employed in food production, such as cheese, beer, wine, bread, and other dairy products. At the same time, certain microorganisms are pathogens, including E. coli, Salmonella, Listeria, Norovirus, and Staphylococcus aureus, which can cause harm to the human body. Therefore, microbiology testing and microbial detection assist in ensuring quality control to provide product safety in the pharmaceutical manufacturing, food and beverage, and cosmetics sectors.
The cases of infection are increasing globally. The most common types of infections in the human body are blood infections, respiratory tract infections, digestive tract infections, hepatitis B infections, and skin infections. Microbiological testing helps to find the cause of the disease. Early detection and timely treatment using the right antibiotics are important steps to destroy the cause of the disease completely. The most common methods used for microbiology testing analysis include the spread plate method, pour plate method, multiple-tube fermentation (MPN) method, and membrane filtration method.
The microbiology testing market is driven by several factors, including technological advancements in microbiology testing, growing health concerns among individuals, increasing incidence of infection, growing healthcare expenditure, an increase in pharmaceutical production, growing demand for point-of-care testing, and rising investment in research and development activities. Additionally, the market is growing as a result of increasing global awareness of foodborne illnesses and robust demand for safe quality food items, which has increased the need for microbiology testing in the food and beverage industry.
| Report Coverage | Details |
| Market Revenue in 2023 | USD 5.33 Billion |
| Projected Forecast Revenue by 2032 | USD 11.76 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.2% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
North America is expected to dominate the market due to several factors. The region's growth is driven by the presence of advanced healthcare infrastructure, rising private and public funding for research on infectious diseases, implementation of stringent regulatory policies, strong emphasis on food safety, rising incidence of infectious diseases, and advancement in technology. Diseases such as respiratory diseases, bloodstream infections, sexually transmitted diseases, and urinary tract infections also fuel the market growth. A report published by the Centers for Disease Control and Prevention (CDC) showed that flu has resulted in 9.4 million to 41 million illnesses, 100,000 to 710,000 hospitalizations, and 4,900 to 52,000 deaths each year between 2010 and 2022.
The United States held the largest revenue share in the region due to the presence of key market players, an increasing number of pharmaceutical and biotechnology companies, innovation in testing technologies, an increasing number of aerobic and anaerobic tests, and sophisticated medical infrastructures, such as hospitals and clinical labs. Furthermore, the growing prevalence of diseases requiring these microbiological services drives the industry. According to the data published by the Centers for Disease Control and Prevention in June 2022, it is estimated that in the last five years, nearly 14,000 to 25,000 cases of invasive group A strep disease occurred annually in the US. For instance, Gonorrhea is the second most commonly reported bacterial sexually transmitted infection in the US. A significant rise in the presence of prominent market players in the Canadian market is likely to influence the market's growth positively.
Drivers
Increasing cases of foodborne diseases
The robust growth in the cases of foodborne illnesses is anticipated to boost the growth of the microbiology testing market. It is estimated that around 48 million people get sick from a foodborne- illness, with nearly 128,000 hospitalizations and 3,000 deaths each year in the United States, according to the Centers for Disease Control and Prevention (CDC). In addition, implementing stringent food safety standards, increasing consumer awareness about food safety among individuals, and growing consumer demand for packaged food products are all expected to drive market expansion in the coming years.
Rising prevalence of sexually transmitted diseases
Several sexually transmitted infections, including human immunodeficiency virus (HIV), human papillomavirus (HPV), HBV, and HCV, are rising rapidly, which increases the demand for microbiology testing. For instance, according to an article published by the World Health Organization in July 2023, it is estimated more than 1 million sexually transmitted infections are acquired every day globally, and most of the cases are asymptomatic. There are an estimated that every year 374 million new infections with 1 of 4 curable sexually transmitted infections (STIs) such as chlamydia, trichomoniasis, syphilis, and gonorrhea. Therefore, increasing cases of STI augment the growth of the microbiology testing market during the forecast period.
Restraints
Rising issues laboratory reimbursement
The microbiology testing market's expansion is anticipated to be constrained by laboratory reimbursement issues. The reimbursement for microbiology testing is kind of a complex process. Several undeveloped and developing countries lack standardized reimbursement policies, which is anticipated to hamper the market expansion during the forecast period.
High cost
The high cost of microbiology instruments is expected to hamper the market growth over the forecast period. The high initial and maintenance cost of microbiology instruments may result in less adoption in lower and middle-income countries. Thus, it may impede market growth in the coming years.
Opportunities
Increasing healthcare investments and rise in R&D activities
The rapid rise in healthcare investments coupled with the rise in R&D activities are the leading drivers to fight against infectious diseases and live a healthy life and are projected to offer a lucrative opportunity for market growth during the forecast period. For instance, according to the data by the NIH in January 2023, from 2008 to 2022, the National Institute of Health (NIH) supported funding of 4.5 billion USD to tackle AMR. Such increasing investment in research by the government is boosting the expansion of the microbiology testing market.
Technological advancements and adoption of marketing strategies
The market is witnessing significant advancements in microbiology testing due to the adoption of advanced technology for various diagnostic purposes. In addition, the key market players are adopting various strategies such as product launches, acquisitions, and collaborations to gain competitive advantages, which are projected to create significant growth opportunities for the market during the forecast period.
Market Segmentation
By Product
By Test Type
By Application
By End User
Buy this Research Report@ https://www.precedenceresearch.com/checkout/3406
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
